Anti‐fibrotic activity and enhanced interleukin‐6 production by hepatic stellate cells in response to imatinib mesylate

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Liver international (Print)

• Publication date

  2012-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1478-3231.2012.02806.xPMID 22507133PMCID PMC3370152
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver regeneration.

  2012cited by this paper
• Reversibility of liver fibrosis

  2012cited by this paper
• Targeting non-malignant disorders with tyrosine kinase inhibitors

  2010cited by this paper
• Narrative Review: Fibrotic Diseases: Cellular and Molecular Mechanisms and Novel Therapies

  2010influential reference
• Platelet-derived growth factor receptor tyrosine kinase inhibitors: a review of the recent patent literature

  2010cited by this paper
• Tyrosine kinase inhibitors - a review on pharmacology, metabolism and side effects.

  2009cited by this paper
• Reversibility of liver fibrosis.

  2009cited by this paper
• Hepatic wound repair

  2009cited by this paper
• p75 neurotrophin receptor signaling regulates hepatic myofibroblast proliferation and apoptosis in recovery from rodent liver fibrosis

  2009cited by this paper
• Therapeutic targeting of the PDGF and TGF-β-signaling pathways in hepatic stellate cells by PTK787/ZK22258

  2009cited by this paper
• Experimental Therapeutics, Molecular Targets, and Chemical Biology Imatinib Mesylate Induces Cisplatin Hypersensitivity in Bcr-Abl + Cells by Differential Modulation of p53 Transcriptional and Proapoptotic Activity

  2009cited by this paper
• PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling

  2009cited by this paper
• Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis.

  2008cited by this paper
• p75 Neurotrophin receptor is a marker for precursors of stellate cells and portal fibroblasts in mouse fetal liver.

  2008cited by this paper
• Mechanisms of hepatic fibrogenesis.

  2008cited by this paper
• Relationships among stellate cell activation, progenitor cells, and hepatic regeneration.

  2008cited by this paper
• Redox mechanisms in hepatic chronic wound healing and fibrogenesis

  2008cited by this paper
• Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological Targeting

  2008cited by this paper
• Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.

  2007cited by this paper
• Liver regeneration

  2007cited by this paper
• Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production

  2007cited by this paper
• Induction of Gas6 protein in CCl4‐induced rat liver injury and anti‐apoptotic effect on hepatic stellate cells

  2006cited by this paper
• PI3K is involved in PDGF-beta receptor upregulation post-PDGF-BB treatment in mouse HSC.

  2006cited by this paper
• Cardiotoxicity of the cancer therapeutic agent imatinib mesylate

  2006cited by this paper
• Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term.

  2006cited by this paper
• Activated hepatic stellate cells overexpress p75NTR after partial hepatectomy and undergo apoptosis on nerve growth factor stimulation

  2006cited by this paper
• Amelioration of liver fibrogenesis by dual inhibition of PDGF and TGF-beta with a combination of imatinib mesylate and ACE inhibitor in rats.

  2006cited by this paper
• Role of poly(ADP-ribose) polymerase activity in imatinib mesylate-induced cell death

  2005cited by this paper
• Expression patterns of PDGF-A, -B, -C and -D and the PDGF-receptors α and β in activated rat hepatic stellate cells (HSC)

  2005cited by this paper
• Fibrosis correlates with a ductular reaction in hepatitis C: Roles of impaired replication, progenitor cells and steatosis

  2005cited by this paper
• Expression patterns of PDGF-A, -B, -C and -D and the PDGF-receptors alpha and beta in activated rat hepatic stellate cells (HSC).

  2005cited by this paper
• Molecularly targeted therapy for gastrointestinal cancer.

  2005influential reference
• Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats.

  2005cited by this paper
• Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression.

  2005cited by this paper
• Bioconductor: open software development for computational biology and bioinformatics

  2004cited by this paper
• Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis

  2004cited by this paper
• Imatinib-Mesylate Blocks Recombinant T-Type Calcium Channels Expressed in Human Embryonic Kidney-293 Cells by a Protein Tyrosine Kinase-Independent Mechanism

  2004cited by this paper
• Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis

  2003cited by this paper
• Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.

  2003cited by this paper
• Proangiogenic role of tumor‐activated hepatic stellate cells in experimental melanoma metastasis

  2003cited by this paper
• Summaries of Affymetrix GeneChip probe level data.

  2003cited by this paper
• PDGF and signal transduction in hepatic stellate cells.

  2002cited by this paper
• [Mechanisms of hepatic fibrogenesis].

  2002cited by this paper
• Discoidin Domain Receptor 2 Regulates Fibroblast Proliferation and Migration through the Extracellular Matrix in Association with Transcriptional Activation of Matrix Metalloproteinase-2*

  2002cited by this paper
• STI571 (Gleevec) as a paradigm for cancer therapy.

  2002cited by this paper
• In silico prediction of protein-protein interactions in human macrophages

  2001cited by this paper
• Upstream Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) Element-1, a Novel and Essential Regulatory DNA Motif in the Human TIMP-1 Gene Promoter, Directly Interacts with a 30-kDa Nuclear Protein*

  2000cited by this paper
• Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing

  1998cited by this paper
• Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice

  1996cited by this paper
• Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture.

  1994cited by this paper
• Cell-specific expression of hepatocyte growth factor in liver. Upregulation in sinusoidal endothelial cells after carbon tetrachloride.

  1993cited by this paper
• Isolated hepatic lipocytes and kupffer cells from normal human liver: Morphological and functional characteristics in primary culture

  1992cited by this paper
• Hepatocyte growth factor/hepatopoietin A is expressed in fat‐storing cells from rat liver but not myofibroblast‐like cells derived from fat‐storing cells

  1992cited by this paper
• Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product.

  1991cited by this paper
• Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors.

  1989cited by this paper
• Thioacetamide-induced cirrhosis-like liver lesions in rats--usefulness and reliability of this animal model.

  1988cited by this paper

• Using Microfluidic Hepatic Spheroid Cultures to Assess Liver Toxicity of T-2 Mycotoxin

  2024cites this paper
• Polyenylphosphatidylcholines as bioactive excipient in tablets for the treatment of liver fibrosis.

  2023cites this paper
• Therapy that Targets Growth Factor Receptors: Novel Approach for Liver Cirrhosis Treatment

  2021cites this paper
• Macromolecular Crowding as a Tool to Screen Anti-fibrotic Drugs: The Scar-in-a-Jar System Revisited

  2021cites this paper
• Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis.

  2021cites this paper
• Gut-liver The role of serotonin and its pathways in hepatic fibrogenesis

  2021cites this paper
• Different roles of interleukin 6 and interleukin 11 in the liver: implications for therapy

  2020cites this paper
• The effect of fermented Glycine max (L.) Merr. to rats induced CCl4 toward hepatic IL-6 expression and ALT-AST level

  2020cites this paper
• Resveratrol increases the activation markers and changes the release of inflammatory cytokines of hepatic stellate cells

  2020cites this paper
• Effects of Combined Admistration of Imatinib and Sorafenib in a Murine Model of Liver Fibrosis

  2020cites this paper
• Predictive Value of Precision-Cut Kidney Slices as an Ex Vivo Screening Platform for Therapeutics in Human Renal Fibrosis

  2020cites this paper
• ZEB1 regulates the activation of hepatic stellate cells through Wnt/β-catenin signaling pathway.

  2019cites this paper
• TMEM100 mediates inflammatory cytokines secretion in hepatic stellate cells and its mechanism research.

  2019cites this paper
• Receptor tyrosine kinase inhibitors cause dysfunction in adult rat cardiac fibroblasts in vitro.

  2019cites this paper
• TMEM9 mediates IL‐6 and IL‐1&bgr; secretion and is modulated by the Wnt pathway

  2018cites this paper
• Desmoplastic Tumor Microenvironment and Immunotherapy in Cholangiocarcinoma.

  2018cites this paper
• Sorafenib and praziquantel synergistically attenuate Schistosoma japonicum-induced liver fibrosis in mice

  2018cites this paper
• Hepatic stellate cells as key target in liver fibrosis.

  2017cites this paper
• TMEM88 mediates inflammatory cytokines secretion by regulating JNK/P38 and canonical Wnt/β-catenin signaling pathway in LX-2 cells

  2017cites this paper
• Ductular reaction correlates with fibrogenesis but does not contribute to liver regeneration in experimental fibrosis models

  2017cites this paper
• PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics

  2017cites this paper
• Hepatic stellate cell‐targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis

  2017cites this paper
• The effect of combined inositol hexakisphosphate and inositol supplement in streptozotocin‐induced type 2 diabetic rats

  2016cites this paper
• Drugs of abuse and addiction: A slippery slope toward liver injury.

  2016cites this paper
• Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension.

  2016cites this paper
• Polymeric Nanocarriers for Delivery of Small Molecules and miRNAs for the Treatment of Liver Fibrosis and Pancreatic Cancer

  2016cites this paper
• STAT3 Inhibition Suppresses Hepatic Stellate Cell Fibrogenesis: HJC0123, a Potential Therapeutic Agent for Liver Fibrosis.

  2016cites this paper
• Imatinib accelerates progenitor cell‐mediated liver regeneration in choline‐deficient ethionine‐supplemented diet‐fed mice

  2016cites this paper
• Platelet Derived Growth Factor Has a Role in Pressure Induced Bladder Smooth Muscle Cell Hyperplasia and Acts in a Paracrine Way.

  2015cites this paper
• Role of fibrogenic and inflammatory cytokines in HCV-induced fibrosis

  2015cites this paper
• β-PDGF Receptor Expressed by Hepatic Stellate Cells Regulates Fibrosis in Murine Liver Injury, but Not Carcinogenesis

  2015cites this paper
• NLRC5 Mediates IL-6 and IL-1β Secretion in LX-2 Cells and Modulated by the NF-κB/Smad3 Pathway

  2015cites this paper
• Integral Role of Platelet-Derived Growth Factor in Mediating Transforming Growth Factor-β1–Dependent Mesenchymal Stem Cell Stiffening

  2014cites this paper
• Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs.

  2014cites this paper
• Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer

  2014cites this paper
• Desmoplastic stroma and cholangiocarcinoma: Clinical implications and therapeutic targeting

  2014cites this paper
• Delivery and Targeting of miRNAs for Treating Liver Fibrosis

  2014cites this paper